Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study
https://doi.org/10.21886/2308-6424-2019-7-3-59-65
Abstract
Prostatitis is a chronic disease that does not respond well to therapy. It is prone to frequent relapses and does not have a clear and unambiguous clinical picture, which can lead to diagnostic failure. A case of overactive bladder and myofascial syndrome described. The clinical picture was interpreted as «chronic prostatitis» erroneously. Differentiated analysis of the International Prostate Symptom Score (IPSS) and NIH-CPSI (National Institute of Health Chronic Prostatitis Symptom Index) questionnaires, as well as palpation of trigger points made it possible to establish the correct diagnosis. The following drugs were prescribed: Trospium chloride (Spasmex® ) 15 mg twice a day, Baclоfen (Baclophenum) 10 mg daily, Combilipen (B vitamins multicomplex) intramuscularly, Nimesulide (Nimesulide) orally, and locally low-intensity laser therapy. The patient noted a marked improvement after 14 days: the pain intensity decreased from 8 points to 1, urination urgency was not noted, nocturia stopped. The quality of life (QoL) accordingly improved to 1 point on the IPSS scale. The total score for domains III and IV decreased from 11 to 3 according to the NIH-CPSI symptom scale of chronic prostatitis. The pronounced positive dynamics of the patient’s state of health has confirmed the accuracy of the diagnosis and treatment.
About the Authors
E. V. KulchavenyaRussian Federation
Ekaterina V. Kulchavenya – M.D., Ph.D. (M), D.M.S., Full Professor; Chief Researcher, Head, Dept. of Urology for Patients with Urogenital Tuberculosis, Novosibirsk Research Institute of Tuberculosis; Professor, Dept. of Tuberculosis, Novosibirsk State Medical University
Novosibirsk
A. A. Baranchukova
Russian Federation
Anzhelika A. Baranchukova – M.D., Ph.D. doct.cand. (M), Associate Professor, Dept. of Tuberculosis
Novosibirsk
References
1. Almeida F, Santos Silva A, Silva Pinto A, Sarmento A. Chronic prostatitis caused by extended-spectrum β-lactamaseproducing Escherichia coli managed using oral fosfomycin-A case report. IDCases. 2019;15:e00493. DOI: 10.1016/j.idcr.2019.e00493
2. Maurizi A, De Luca F, Zanghi A, Manzi E, Leonardo C, Guidotti M, Antonaccio FP, Olivieri V, De Dominicis C. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids. Arch Ital Urol Androl. 2019;90(4):260-264. DOI: 10.4081/aiua.2018.4.260
3. Zhanel GG, Zhanel MA1, Karlowsky JA. Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli. Can J Infect Dis Med Microbiol. 2018;2018:1404813. DOI: 10.1155/2018/1404813
Review
For citations:
Kulchavenya E.V., Baranchukova A.A. Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study. Urology Herald. 2019;7(3):59-65. (In Russ.) https://doi.org/10.21886/2308-6424-2019-7-3-59-65